MarketLine Company Profile: Natco Pharma Ltd.

Natco Pharma (Natco) is engaged in the manufacture and distribution of bulk drug and drug intermediaries and formulations. The company offers a range of products in the fields of oncology and pharmaceuticals. It also exports active pharmaceutical ingredients (APIs) and finished dosage forms to the Americas, Europe, the Middle East and South East Asia. Natco operates in India, Canada, the US, Mauritius and Brazil. It is headquartered in Hyderabad, India, and employs around 2,500 people. The company recorded revenues of INR7,388.9 million (approximately $123 million) in the fiscal year ended March 2014, an increase of 11.9% over 2013. The company's operating profit was INR1,507.5 million (approximately $25.1 million) in fiscal 2014, a decrease of 23.1% compared to 2013. Its net profit was INR1,027.3 million (approximately $17.1 million) in fiscal 2014, an increase of 42.9% over 2013. [ABSTRACT FROM AUTHOR]

Copyright of Natco Pharma Limited MarketLine Company Profile is the property of MarketLine, a Progressive Digital Media business and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)